Dan Roden

December 6, 2011

Study points to personal treatment for atrial fibrillation

Individuals with atrial fibrillation who have a particular genetic variant respond better to rate control therapy.

By Kathy Whitney

October 28, 2011

Vanderbilt doctors to screen patients taking statins for genetic risk factors

Vanderbilt University Medical Center doctors announced today they will begin screening patients who take commonly prescribed statin drugs for a rare genetic variation that can increase risks for side effects from these drugs such as muscle aches, kidney damage and even death.

By Craig Boerner

April 15, 2011

Vanderbilt: Laboratory for health care reform

By Bill Snyder